US HB4408 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 30 2023 - 25% progression
Action: 2023-07-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 30 2023 - 25% progression
Action: 2023-07-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
Title
Promising Pathway Act
Sponsors
| Rep. Mike Gallagher [R-WI] | Rep. Mike Quigley [D-IL] | Rep. Bruce Westerman [R-AR] | Rep. Eric Swalwell [D-CA] |
| Rep. Brian Fitzpatrick [R-PA] | Rep. Anthony D'Esposito [R-NY] | Rep. Dean Phillips [D-MN] | Rep. Joe Wilson [R-SC] |
| Rep. Josh Gottheimer [D-NJ] | Rep. Lois Frankel [D-FL] | Rep. Mike Garcia [R-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-07-07 | House | Referred to the Subcommittee on Health. |
| 2023-06-30 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-06-30 | House | Introduced in House |
Same As/Similar To
SB1906 (Same As) 2023-06-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/4408/all-info |
| Text | https://www.congress.gov/118/bills/hr4408/BILLS-118hr4408ih.pdf |
